[Congressional Record Volume 167, Number 86 (Tuesday, May 18, 2021)]
[Senate]
[Pages S2734-S2735]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1504. Mr. JOHNSON (for himself and Mr. Cotton) submitted an 
amendment intended to be proposed to amendment SA 1502 proposed by Mr. 
Schumer to the bill S. 1260, to establish a new Directorate for 
Technology and Innovation in the National Science Foundation, to 
establish a regional technology hub program, to require a strategy and 
report on economic security, science, research, innovation, 
manufacturing, and job creation, to establish a critical supply chain 
resiliency program, and for other purposes; which was ordered to lie on 
the table; as follows:

       At the appropriate place in division F, insert the 
     following:

     SEC. __. FENTANYL-RELATED SUBSTANCES.

       (a) Amendments.--Section 202(c) of the Controlled 
     Substances Act (21 U.S.C. 812(c)) is amended--
       (1) by adding at the end of subsection (b) of Schedule I 
     the following:
       ``(23) Isobutyryl fentanyl.
       ``(24) Para-Methoxybutyrylfentanyl.
       ``(25) Valeryl fentanyl.
       ``(26) Cyclopentyl fentanyl.
       ``(27) Para-Chloroisobutyryl fentanyl.''; and
       (2) by adding at the end of Schedule I the following:
       ``(e)(1) Unless specifically exempted or unless listed in 
     another schedule, any material, compound, mixture, or 
     preparation which contains any quantity of fentanyl-related 
     substances, or which contains their salts, isomers, and salts 
     of isomers whenever the existence of such salts, isomers, and 
     salts of isomers is possible within the specific chemical 
     designation.
       ``(2) In paragraph (1), the term `fentanyl-related 
     substances' includes the following:
       ``(A) Any substance that is structurally related to 
     fentanyl by one or more of the following modifications:

[[Page S2735]]

       ``(i) By replacement of the phenyl portion of the phenethyl 
     group by any monocycle, whether or not further substituted in 
     or on the monocycle.
       ``(ii) By substitution in or on the phenethyl group with 
     alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or 
     nitro groups.
       ``(iii) By substitution in or on the piperidine ring with 
     alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, 
     haloalkyl, amino or nitro groups.
       ``(iv) By replacement of the aniline ring with any aromatic 
     monocycle whether or not further substituted in or on the 
     aromatic monocycle.
       ``(v) By replacement of the N-propionyl group by another 
     acyl group.
       ``(B) 4'-Methyl acetyl fentanyl.
       ``(C) Crotonyl fentanyl.
       ``(D) 2'-Fluoro ortho-fluorofentanyl.
       ``(E) Ortho-Methyl acetylfentanyl.
       ``(F) Thiofuranyl fentanyl.
       ``(G) Ortho-Fluorobutyryl fentanyl.
       ``(H) Ortho-Fluoroacryl fentanyl.
       ``(I) Beta-Methyl fentanyl.
       ``(J) Phenyl fentanyl.
       ``(K) Para-Methylfentanyl.
       ``(L) Beta'-Phenyl fentanyl.
       ``(M) Benzodioxole fentanyl.''.
       (b) Effective Date.--This section shall take effect 1 day 
     after the date of enactment of this Act.
                                 ______